The effects of the immunosuppressant rapamycin on the growth of rheumatoid arthritis (RA) synovial fibroblast

Clinical and Experimental Immunology

Volumn 104, Issue 1, 1996, Pages 86-91

  Migita, K ^a   Eguchi, K ^a   Aoyagi, T ^b   Tsukada, T ^a   Tsuboi, M ^a   Kawabe, Y ^a   Nagataki, S ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Ureshino Medical Center   (Japan)

Author keywords

protein kinase; rapamycin; rheumatoid arthritis; synovial fibroblast

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; PLATELET DERIVED GROWTH FACTOR; PROTEIN TYROSINE KINASE; RAPAMYCIN;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; CLINICAL ARTICLE; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS; SYNOVIUM;

EID: 0030012736     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-651.x     Document Type: Article

References (29)

1. Hamilton JA. Hypothesis: in vitro evidence for invasive and tumor like properties of rheumatoid pannus. J Rheumatol 1983; 10:845-51.
2. Bromley M, Wooley DE. Histopathology of the rheumatoid lesion: identification of cell types at sites of cartilage erosion. Arthritis Rheum 1984; 27:857-63.
3. Koch A, Polverini PJ, Leibovitch SJ. Stimulation of neovascularization by human synovial tissue macrophages. Arthritis Rheum 1986; 29:471-9.
4. Wood DD, Ihrie EJ, Dinarello CA, Cohen PL. Isolation of an interleukin-1 like factor from human joint effusions. Arthritis Rheum 1983; 26:975-83.
5. Sano H, Forough R, Marier JAM et al. Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritis joint. J Cell Biol 1990; 110:1417-26.
6. Melnyk VO, Shipley GO, Sternfeld MD, Sherman L, Rosenbaum JT. Synoviocytes synthesize, bind and respond to basic fibroblast growth factor. Arthritis Rheum 1990; 33:493-500.
7. Remmers EF, Sano H, Lafyatis R et al. Production of platelet derived growth factor B chain (PDGF-B/c-cis) mRNA and immunoreactive PDGF B-like polypeptide by rheumatoid synovium: coexpression with heparin binding acid fibroblast growth factor-1. J Rheumatol 1991; 18:7-13.
8. Sano H, Engleka K, Mathern P et al. Coexpression of phosphotyrosine-containing proteins, platelet-derived growth factor-B, and fibroblast growth factor-1 in situ in synovial tissues of patients with rheumatoid arthritis and Lewis rats with adjuvant of streptococcal cell wall arthritis. J Clin Invest 1993; 91:553-65.
9. Ralston R, Bishop JM. The product of the protooncogene c-src is modified during the cellular response to platelet-derived growth factor. Proc Natl Acad Sci USA 1985; 82:7845-9.
10. Kypta RM, Goldberg Y, Ulug EJ, Courtneidge SA. Association between the PDGF receptor and members of the src family tyrosine kinase. Cell 1990; 62:481-92.
11. De Vivo M, Iyengar R. Activated Gq-alpha potentiates platelet-derived growth factor-stimulated mitogenesis in confluent cell cultures. J Biol Chem 1994; 269:19671-4.
12. s6k activation mediated by phosphatidylinositol -3-OH kinase. Nature 1994; 370:71-5.
13. Sehgal SN, Baker H, Verina C. Rapamycin (AY-22989), a new fungal antibiotic. I. Toxonomy of the producing streptomycete and isolation of the active principle. J Antibiotics 1975; 28:721-6.
14. Calvo V, Crews CM, Vik TA, Bierer BF. Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin. Proc Natl Acad Sci USA 1992; 89:7571-5.
15. Wood KW, Sarenecki C, Roberts TM, Blenis J. ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell 1992; 68:1041-50.
16. ras in activation of extracellular signal-regulated kinase 2. Nature 1992; 357:602-4.
17. Kuo CJ, Chung J, Fiorentino DF, Flanagan WN, Blenis J, Crabtree GR. Rapamycin selectively inhibits interleukin-2 activation of P70 S6 kinase. Nature 1992; 358:70-3.
18. Migita K, Ochi A. Induction of clonal anergy by oral administration of staphylococcal enterotoxin B. Eur J Immunol 1994; 24:2081-6.
19. Fruman DA, Burakoff SJ, Biere BE. Immunophilins in protein folding and immunosuppression. FASEB J 1994; 8: 391-400.
20. Price DJ, Grove JR, Calvo V, Avuruch J, Bierer BE. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science 1992; 257:973-7.
21. Banerjee P, Ahmad MF, Grave JR, Kozlosky C, Price DJ, Avruch J. Molecular structure of a insulin/mitogen-activated 70-kDa S6 kinase. Proc Natl Acad Sci USA 1990; 87:8550-4.
22. rsk) in somatic cells: phosphorylation and activation during initiation of cell proliferation. Mol Cell Biol 1990; 10:3204-15.
23. Ferrari S, Bandi HR, Hobsteenge J, Bussian BM, Thomas G. Mitogen-activated 70K S6 kinase. Identification of in vitro 40S ribosomal S6 phosphorylation site. J Biol Chem 1991; 266:22770-5.
24. Erikson RL. Structure, expression, and regulation of protein kinase involved in phosphorylation of ribosomal S6. J Biol Chem 1991; 266:6007-10.
25. Chung J, Kuo CJ, Crabtree GR, Blenis J. Rapamycin-FKBP specificially blocks growth-dependent activation and signaling by the 70kD S6 protein kinase. Cell 1992; 69:1227-36.
26. Qu Z, Garcia CH, O'Rourke LM, Planck SR, Kohli M, Rosenbaum JT. Local poliferation of fibroblast-like synoviocytes contributes synovial hyperplasia. Results of proliferating cell nuclear antigen/ cyclin, C-myc, and nuclear organizer region staining. Arthritis Rheum 1994; 37:212-20.
27. 2+ concentration. Biochem Biophys Res Commun 1992; 188:1198-204.
28. Rivera VM, Miranti CK, Misra RP, Ginty DD, Chen RH, Blenis J, Greenberg ME. A growth factor-induced kinase phosphorylates the serum response factor at a site that regulates its DNA-binding activity. Mol Cell Biol 1993; 13:6260-73.
29. Morris RE. Rapamycin. FK506's fraternal twin or distant cousin? Immunol Today 1991; 12:137-40.